---
document_datetime: 2025-11-23 07:24:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/docetaxel-mylan-0.html
document_name: docetaxel-mylan-0.html
version: success
processing_time: 0.1057872
conversion_datetime: 2025-12-27 09:58:20.396971
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Docetaxel Mylan

[RSS](/en/individual-human-medicine.xml/66631)

##### Lapsed

This medicine's authorisation has lapsed

docetaxel

Medicine

Human

Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 January 2015, the marketing authorisation of Docetaxel Mylan (docetaxel) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, MYLAN S.A.S., had not marketed Docetaxel Mylan in the EU since its initial marketing authorisation in January 2012. In accordance with provisions of the sunset clause, the marketing authorisation of the medicinal product lapsed as the product had not been marketed in any of the EU Member States within three years of its initial authorisation. MYLAN S.A.S. confirmed that the product had not been marketed due to commercial reasons.

Docetaxel Mylan was granted marketing authorisation in the EU on 31 January 2012 for treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma and head and neck cancer.

Docetaxel Mylan is a generic medicine of Taxotere. There are other generic medicinal products of Taxotere authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Docetaxel Mylan is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Docetaxel Mylan : EPAR - Summary for the public

Reference Number: EMA/949959/2011

English (EN) (526.06 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 12/03/2015

[View](/en/documents/overview/docetaxel-mylan-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-926)

български (BG) (625.59 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/bg/documents/overview/docetaxel-mylan-epar-summary-public_bg.pdf)

español (ES) (528.56 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/es/documents/overview/docetaxel-mylan-epar-summary-public_es.pdf)

čeština (CS) (592.84 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/cs/documents/overview/docetaxel-mylan-epar-summary-public_cs.pdf)

dansk (DA) (526.4 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/da/documents/overview/docetaxel-mylan-epar-summary-public_da.pdf)

Deutsch (DE) (529.74 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/de/documents/overview/docetaxel-mylan-epar-summary-public_de.pdf)

eesti keel (ET) (526.7 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/et/documents/overview/docetaxel-mylan-epar-summary-public_et.pdf)

ελληνικά (EL) (632.45 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/el/documents/overview/docetaxel-mylan-epar-summary-public_el.pdf)

français (FR) (588.99 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fr/documents/overview/docetaxel-mylan-epar-summary-public_fr.pdf)

italiano (IT) (65.42 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/it/documents/overview/docetaxel-mylan-epar-summary-public_it.pdf)

latviešu valoda (LV) (573.02 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lv/documents/overview/docetaxel-mylan-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (613.9 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lt/documents/overview/docetaxel-mylan-epar-summary-public_lt.pdf)

magyar (HU) (586.27 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/hu/documents/overview/docetaxel-mylan-epar-summary-public_hu.pdf)

Malti (MT) (593.05 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/mt/documents/overview/docetaxel-mylan-epar-summary-public_mt.pdf)

Nederlands (NL) (528.65 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/nl/documents/overview/docetaxel-mylan-epar-summary-public_nl.pdf)

polski (PL) (593.08 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pl/documents/overview/docetaxel-mylan-epar-summary-public_pl.pdf)

português (PT) (526.26 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pt/documents/overview/docetaxel-mylan-epar-summary-public_pt.pdf)

română (RO) (613.85 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/ro/documents/overview/docetaxel-mylan-epar-summary-public_ro.pdf)

slovenčina (SK) (650.97 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sk/documents/overview/docetaxel-mylan-epar-summary-public_sk.pdf)

slovenščina (SL) (647.28 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sl/documents/overview/docetaxel-mylan-epar-summary-public_sl.pdf)

Suomi (FI) (601.27 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fi/documents/overview/docetaxel-mylan-epar-summary-public_fi.pdf)

svenska (SV) (588.61 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sv/documents/overview/docetaxel-mylan-epar-summary-public_sv.pdf)

## Product information

Docetaxel Mylan : EPAR - Product Information

English (EN) (2.23 MB - PDF)

**First published:** 17/02/2012

**Last updated:** 12/03/2015

[View](/en/documents/product-information/docetaxel-mylan-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-116)

български (BG) (5.74 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/bg/documents/product-information/docetaxel-mylan-epar-product-information_bg.pdf)

español (ES) (2.36 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/es/documents/product-information/docetaxel-mylan-epar-product-information_es.pdf)

čeština (CS) (4.13 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/cs/documents/product-information/docetaxel-mylan-epar-product-information_cs.pdf)

dansk (DA) (2.24 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/da/documents/product-information/docetaxel-mylan-epar-product-information_da.pdf)

Deutsch (DE) (2.44 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/de/documents/product-information/docetaxel-mylan-epar-product-information_de.pdf)

eesti keel (ET) (2.38 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/et/documents/product-information/docetaxel-mylan-epar-product-information_et.pdf)

ελληνικά (EL) (5.75 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/el/documents/product-information/docetaxel-mylan-epar-product-information_el.pdf)

français (FR) (2.42 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fr/documents/product-information/docetaxel-mylan-epar-product-information_fr.pdf)

hrvatski (HR) (2.44 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/hr/documents/product-information/docetaxel-mylan-epar-product-information_hr.pdf)

íslenska (IS) (2.39 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/is/documents/product-information/docetaxel-mylan-epar-product-information_is.pdf)

italiano (IT) (1.02 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/it/documents/product-information/docetaxel-mylan-epar-product-information_it.pdf)

latviešu valoda (LV) (2.45 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lv/documents/product-information/docetaxel-mylan-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.64 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lt/documents/product-information/docetaxel-mylan-epar-product-information_lt.pdf)

magyar (HU) (4.4 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/hu/documents/product-information/docetaxel-mylan-epar-product-information_hu.pdf)

Malti (MT) (4.99 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/mt/documents/product-information/docetaxel-mylan-epar-product-information_mt.pdf)

Nederlands (NL) (2.38 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/nl/documents/product-information/docetaxel-mylan-epar-product-information_nl.pdf)

norsk (NO) (2.33 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/no/documents/product-information/docetaxel-mylan-epar-product-information_no.pdf)

polski (PL) (4.8 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pl/documents/product-information/docetaxel-mylan-epar-product-information_pl.pdf)

português (PT) (2.35 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pt/documents/product-information/docetaxel-mylan-epar-product-information_pt.pdf)

română (RO) (2.64 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/ro/documents/product-information/docetaxel-mylan-epar-product-information_ro.pdf)

slovenčina (SK) (4.22 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sk/documents/product-information/docetaxel-mylan-epar-product-information_sk.pdf)

slovenščina (SL) (4.21 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sl/documents/product-information/docetaxel-mylan-epar-product-information_sl.pdf)

Suomi (FI) (2.27 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fi/documents/product-information/docetaxel-mylan-epar-product-information_fi.pdf)

svenska (SV) (2.29 MB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sv/documents/product-information/docetaxel-mylan-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0006 01/02/2015

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Docetaxel Mylan : EPAR - All Authorised presentations

English (EN) (473.37 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 12/03/2015

[View](/en/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-335)

български (BG) (526.2 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/bg/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_bg.pdf)

español (ES) (473.64 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/es/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_es.pdf)

čeština (CS) (517.27 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/cs/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (473.47 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/da/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (473.74 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/de/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (473.25 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/et/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (526.47 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/el/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_el.pdf)

français (FR) (473.32 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fr/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (501.07 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/hr/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (473.82 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/is/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_is.pdf)

italiano (IT) (19.2 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/it/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (501.74 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lv/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (500.75 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/lt/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (498.45 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/hu/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (517.7 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/mt/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (474.09 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/nl/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (473.32 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/no/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_no.pdf)

polski (PL) (518.1 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pl/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_pl.pdf)

português (PT) (473.96 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/pt/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_pt.pdf)

română (RO) (501.89 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/ro/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (513.91 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sk/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (486.4 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sl/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (473.59 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/fi/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (473.43 KB - PDF)

**First published:**

17/02/2012

**Last updated:**

12/03/2015

[View](/sv/documents/all-authorised-presentations/docetaxel-mylan-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Docetaxel Mylan Active substance docetaxel International non-proprietary name (INN) or common name docetaxel Therapeutic area (MeSH)

- Head and Neck Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma
- Prostatic Neoplasms
- Breast Neoplasms

Anatomical therapeutic chemical (ATC) code L01CD02

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Treatment of breast cancer, special forms of lung cancer (non-small-cell lung cancer), prostate cancer, gastric cancer, or head and neck cancer.

## Authorisation details

EMA product number EMEA/H/C/002317

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Mylan S.A.S.

117 allée des Parcs

Marketing authorisation issued 31/01/2012 Lapse of marketing authorisation 31/01/2015 Revision 6

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Docetaxel Mylan : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (543.96 KB - PDF)

**First published:** 21/06/2012

**Last updated:** 12/03/2015

[View](/en/documents/procedural-steps-after/docetaxel-mylan-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Docetaxel Mylan : EPAR - Public assessment report

Adopted

Reference Number: EMA/40836/2012

English (EN) (650.94 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 12/03/2015

[View](/en/documents/assessment-report/docetaxel-mylan-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Docetaxel Mylan

Adopted

Reference Number: EMA/CHMP/858298/2011

English (EN) (532.26 KB - PDF)

**First published:** 18/11/2011

**Last updated:** 12/03/2015

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-docetaxel-mylan_en.pdf)

**This page was last updated on** 12/03/2015

## Share this page

[Back to top](#main-content)